Meloxicam exerts neuroprotection on spinal cord trauma in rats

International Journal of Neuroscience

Volumn 121, Issue 3, 2011, Pages 142-148

  Hakan, Tayfun ^a   Toklu, Hale Zerrin ^b   Biber, Necat ^a   Celik, Hasan ^a   Erzik, Can ^b   Oǧünç, Ayliz Velioǧlu ^b   Çetinel, Şule ^b   Şener, Göksel ^b  

^a Fiziksel Tip ve Rehabilitasyon Klini i   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

COX 2; glutathione; lipid peroxidation; meloxicam; neuroprotection; spinal cord injury

Indexed keywords

DNA; GLUTATHIONE; MALONALDEHYDE; MELOXICAM; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DECAPITATION; DNA DAMAGE; DNA FRAGMENTATION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SPINAL CORD; SPINAL CORD INJURY;

ANIMALS; CHEMILUMINESCENT MEASUREMENTS; CYCLOOXYGENASE 2 INHIBITORS; DNA FRAGMENTATION; GLUTATHIONE; LIPID PEROXIDATION; MALONDIALDEHYDE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PEROXIDASE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SPINAL CORD; SPINAL CORD INJURIES; THIAZINES; THIAZOLES;

EID: 79952131896     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.537415     Document Type: Article

References (30)

1. Adachi, K., Yimin Y., Satake K., Matsuyama, Y., Ishiguro N., Sawada, M., et al. (2005). Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. Neuroscience Research, 51(1), 73-80. (Pubitemid 39642882)
2. Agha, A. M., El-Khatib, A. S., & Al-Zuhair, H. (1999). Modulation of oxidant status by meloxicam in experimentally induced arthritis. Pharmacology Research, 40, 385-392. (Pubitemid 29472067)
3. Allen, A. R. (1911). Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA, 57, 878-880.
4. Arafa, H. M., Abdel-Wahab, M. H., El-Shafeey, M. F., Badary, O. A., & Hamada, F. M. (2007). Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. European Journal of Pharmacology, 564(1-3), 181-189. (Pubitemid 46946863)
5. Azbill, R. D., Mu, X., Bruce-Keller, A. J., Mattson, M. P., & Springer, J. E. (1997). Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Research, 765(2), 283-290.
6. Beutler, E., Duron, O., & Kelly, B. M. (1963). Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine, 61, 882-888.
7. Buege, J. A., & Aust, S. D. (1978). Microsomal lipid peroxidation. Methods in Enzymology, 53, 302-311.
8. Burton, K. (1968). Determination of DNA concentration with diphenylamine. Methods in Enzymology, 12(2), 163-166.
9. Cemil, B., Topuz, K., Demircan, M. N., Kurt, G., Tun, K., Kutlay, M., et al. (2010). Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochirugica (Wien), 152(9), 1583-1590.
10. Emerit, J., Edeas, M., & Bricaire, F. (2004). Neurodegenerative diseases and oxidative stress. Biomedicine and Pharmacotherapy, 58(1), 39-46. (Pubitemid 38117047)
11. Engelhardt, G., Bogel, R., Schnitzler, C., & Utzmann, R. (1996). Meloxicam: Influence on arachidonic acid metabolism. Part II. In vivo findings. Biochemistry and Pharmacology, 51, 29-38.
12. Gale, K, Kerasidis, H, & Wrathall, J. R. (1985). Spinal cord contusion in the rat: Behavioral analysis of functional neurologic impairment. Experimental Neurology, 88(1), 123-134. (Pubitemid 15114489)
13. Hall, E. D., & Springer, J. E. (2004). Neuroprotection and acute spinal cord injury: A reappraisal. NeuroRx, 1(1), 80-100.
14. Hakan, T., Toklu, H. Z., Biber, N., Ozevren, H., Solakoglu, S., Demirturk, P., et al. (2010). Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood-brain barrier permeability. Neurological Reserarch, 32(6), 629-635.
15. Haklar, G., Yuksel, M., & Yalcin, A. S. (1998). Chemiluminescence in the measurement of free radicals: Theory and application on a tissue injury model. Marmara Medical Journal, 11, 55-60.
16. Hillegass, L. M., Griswold, D. E., Brickson, B., & Albrightson-Winslow C. (1990) Assessment of myeloperoxidase activity in whole rat kidney. Journal of Pharmacological Methods 24(4), 285-295.
17. Kamencic, H., Griebel, R. W., Lyon, A. W., Paterson, P. G., & Juurlink, B. H. (2001). Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB Journal, 15(1), 243-250. (Pubitemid 32061675)
18. Lapchak, P. A., Araujo, D. M., Song, D., & Zivin, J. A. (2001). Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia. Stroke, 32(5), 1220-1225. (Pubitemid 32825814)
19. López-Vales, R., Redensek, A., Skinner, T. A., Rathore, K. I., Ghasemlou, N., Wojewodka, G., et al. (2010). Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. Journal of Neuroscience, 30(9), 3220-3226.
20. Matthias, C., Schuster,M. T., Zieger, S., & Harréus, U. (2006) COX- 2 inhibitors celecoxib and rofecoxib prevent oxidative DNA fragmentation. Anticancer Research, 26(3A), 2003-2007. (Pubitemid 43989461)
21. Minghetti, L., & Levi, G. (1998). Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Progress Neurobiology, 54(1), 99-125. (Pubitemid 28049822)
22. Ogino, K., Hatanaka, K., Kawamura, M., Katori, M., & Harada, Y. (1997). Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Pharmacology, 55, 44-53. (Pubitemid 27354666)
23. Pompella, A., Visvikis, A., Paolicchi, A., De Tata, V., & Casini, A. F. (2003). The changing faces of glutathione, a cellular protagonist. Biochemical Pharmacology, 66, 1499-1503. (Pubitemid 38373339)
24. Resnick D. K., Graham S. H., Dixon C. E., & Marion D. W. (1998) Role of cyclooxygenase 2 in acute spinal cord injury. Journal of Neurotrauma, 15(12), 1005-1013. (Pubitemid 28560043)
25. Slemmer, J. E., Shacka, J. J., Sweeney M. I., & Weber J. T. (2008). Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry, 15(4), 404-414. (Pubitemid 351266946)
26. Smith, W. L, & Dewitt, D. L. (1996). Prostaglandin endoperoxide H synthases-1 and -2. Advances in Immunology, 62, 167-215. (Pubitemid 26250630)
27. Strauss, K. I., & Marini, A. M. (2002). Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. Journal of Neurotrauma, 19, 627-638. (Pubitemid 34587305)
28. Tilleux, S., & Hermans, E. (2007). Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. Journal of Neuroscience Research, 85(10), 2059-2070. (Pubitemid 47172138)
29. Toklu, H. Z., Hakan, T., Celik, H., Biber, N., Erzik, C., Ogunc, A. V., et al. (2010). Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats. Journal of Spinal Cord Medicine, 33(4), 401-409.
30. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R., & Turner, N. D. (2004). Glutathione metabolism and its implications for health. Journal of Nutrition, 134(3), 489-492. (Pubitemid 38298485)